Phreesia PHR shares ended the final buying and selling session 13.9% larger at $21.19. The soar got here on a formidable quantity with a higher-than-average variety of shares altering arms within the session. This compares to the inventory’s 12.9% loss over the previous 4 weeks.
Phreesia scored a robust worth enhance, pushed by traders’ optimism surrounding its impending fiscal 2025 third-quarter outcomes, slated to be launched on Dec. 9 after the closing bell. Within the fiscal second quarter, Phreesia reached a vital milestone by crossing over to constructive free money stream, signaling a brand new part to deploy internally generated money to drive stakeholder worth.
This developer of well being care software program is predicted to put up quarterly lack of $0.29 per share in its upcoming report, which represents a year-over-year change of +50%. Revenues are anticipated to be $106 million, up 15.7% from the year-ago quarter.
Earnings and income progress expectations definitely give sense of the potential energy in a inventory, however empirical analysis reveals that tendencies in earnings estimate revisions are strongly correlated with near-term inventory worth actions.
For Phreesia, the consensus EPS estimate for the quarter has remained unchanged over the past 30 days. And a inventory’s worth often does not preserve transferring larger within the absence of any pattern in earnings estimate revisions. So, make sure that to keep watch over PHR going ahead to see if this latest soar can flip into extra energy down the street.
The inventory presently carries a Zacks Rank #2 (Purchase). You may see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here >>>>
Phreesia is a part of the Zacks Medical Information Techniques trade. P3 Well being Companions Inc. PIII, one other inventory in the identical trade, closed the final buying and selling session 5.4% larger at $0.37. PIII has returned -3% prior to now month.
P3 Well being Companions’s consensus EPS estimate for the upcoming report has remained unchanged over the previous month at -$0.03. In comparison with the corporate’s year-ago EPS, this represents a change of +75%. P3 Well being Companions presently boasts a Zacks Rank of #3 (Maintain).
Free At the moment: Cashing in on The Future’s Brightest Power Supply
The demand for electrical energy is rising exponentially. On the similar time, we’re working to cut back our dependence on fossil fuels like oil and pure fuel. Nuclear power is a perfect alternative.
Leaders from the US and 21 different international locations lately dedicated to TRIPLING the world’s nuclear power capacities. This aggressive transition may imply super income for nuclear-related shares – and traders who get in on the motion early sufficient.
Our pressing report, Atomic Alternative: Nuclear Power’s Comeback, explores the important thing gamers and applied sciences driving this chance, together with 3 standout shares poised to profit essentially the most.
Download Atomic Opportunity: Nuclear Energy’s Comeback free today.
Phreesia, Inc. (PHR) : Free Stock Analysis Report
P3 Health Partners Inc. (PIII) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
